Sigilon Therapeutics Inc (SGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 202,304 | N/A | N/A | N/A | 76,069 |
| Receivables | 177 | N/A | N/A | N/A | 136 |
| Other current assets | 0 | 0 | 0 | 0 | 732 |
| TOTAL | $204,210 | $N/A | $N/A | $N/A | $76,937 |
| Non-Current Assets | |||||
| PPE Net | 2,991 | N/A | N/A | N/A | 4,138 |
| Other Non-Current Assets | 17,849 | 0 | 0 | 0 | 641 |
| TOTAL | $20,840 | $N/A | $N/A | $N/A | $4,779 |
| Total Assets | $225,050 | $N/A | $N/A | $N/A | $90,378 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,988 | 0 | 0 | 0 | 2,005 |
| Accrued Expenses | 7,892 | N/A | N/A | N/A | 5,852 |
| Other current liabilities | N/A | N/A | N/A | N/A | 29,140 |
| TOTAL | $47,018 | $N/A | $N/A | $N/A | $40,375 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,807 | N/A | N/A | N/A | 14,868 |
| Deferred Revenues | 31,777 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 12,069 | 0 | 0 | 0 | 90,539 |
| TOTAL | $31,876 | $N/A | $N/A | $N/A | $120,957 |
| Total Liabilities | $78,894 | $N/A | $N/A | $N/A | $168,140 |
| Shareholders' Equity | |||||
| Common Shares | 31 | N/A | N/A | N/A | 5 |
| Retained earnings | -135,928 | N/A | N/A | N/A | -81,320 |
| TOTAL | $146,156 | $N/A | $N/A | $N/A | $-77,762 |
| Total Liabilities And Equity | $225,050 | $0 | $0 | $0 | $90,378 |